Rectal Cancer Tumor Board Monday, May 2, 10:30 - 11:30 am CME Credit Hours: 1 There are now several viable options in managing most rectal cancers. These include numerous options for resection, neoadjuvant treatment, surveillance, and management of metastatic disease. This symposium will review several “real-world” presentations of rectal cancer and discuss various approaches to treatment. Objectives At the conclusion of this session, participants should be able to: Recognize treatments for locally advanced rectal cancer Identify treatments for recurrent rectal cancer Describe treatments for locally advanced rectal cancer Agenda Co-Directors: Jorge Marcet, MD, Tampa, FL Larissa Temple, MD, Rochester, NY Social Media Moderator: Aaron Dawes, MD, Stanford, CA 10:30 am Introduction Jorge Marcet, MD, Houston, TX Larissa Temple, MD, Rochester, NY 10:35 am Cases: Non-operative Management of Rectal Cancer Management of Proximal and Distal Rectal Cancers in Young Patients Management of Advanced Rectal Cancers in the Elderly Management of Locally Invasive and Perforated Rectal Cancer Panel: Matthew Fink, MD, Tampa, FL Matthew Mutch, MD, St. Louis, MO Arun Nagarajan, MD, Weston, FL Rodrigo Pedraza, MD, Portland, OR Larissa Temple, MD, Rochester, NY Kirsten Wilkins, MD, Edison, NJ Robert Zlotecki, MD, PhD, Gainesville, Fl 11:30 am Adjourn